PRME
Price
$1.24
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
162.64M
21 days until earnings call
WHWK
Price
$1.57
Change
+$0.03 (+1.95%)
Updated
Apr 17 closing price
Capitalization
73.45M
19 days until earnings call
Ad is loading...

PRME vs WHWK

Header iconPRME vs WHWK Comparison
Open Charts PRME vs WHWKBanner chart's image
Prime Medicine
Price$1.24
Change-$0.00 (-0.00%)
Volume$457.97K
Capitalization162.64M
Whitehawk Therapeutics
Price$1.57
Change+$0.03 (+1.95%)
Volume$50.28K
Capitalization73.45M
PRME vs WHWK Comparison Chart
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. WHWK commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Hold and WHWK is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (PRME: $1.24 vs. WHWK: $1.57)
Brand notoriety: PRME and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 32% vs. WHWK: 34%
Market capitalization -- PRME: $162.64M vs. WHWK: $73.45M
PRME [@Biotechnology] is valued at $162.64M. WHWK’s [@Biotechnology] market capitalization is $73.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileWHWK’s FA Score has 1 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • WHWK’s FA Score: 1 green, 4 red.
According to our system of comparison, both PRME and WHWK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 4 TA indicator(s) are bullish while WHWK’s TA Score has 5 bullish TA indicator(s).

  • PRME’s TA Score: 4 bullish, 4 bearish.
  • WHWK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, WHWK is a better buy in the short-term than PRME.

Price Growth

PRME (@Biotechnology) experienced а +5.98% price change this week, while WHWK (@Biotechnology) price change was -3.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

PRME is expected to report earnings on May 09, 2025.

WHWK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($163M) has a higher market cap than WHWK($73.5M). WHWK YTD gains are higher at: -50.238 vs. PRME (-57.534).
PRMEWHWKPRME / WHWK
Capitalization163M73.5M222%
EBITDA-196.34MN/A-
Gain YTD-57.534-50.238115%
P/E RatioN/AN/A-
Revenue2.98MN/A-
Total Cash190MN/A-
Total Debt40.8MN/A-
FUNDAMENTALS RATINGS
PRME vs WHWK: Fundamental Ratings
PRME
WHWK
OUTLOOK RATING
1..100
776
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
9689
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
5850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (33) in the Pharmaceuticals Major industry is in the same range as PRME (38) in the null industry. This means that WHWK’s stock grew similarly to PRME’s over the last 12 months.

WHWK's Profit vs Risk Rating (94) in the Pharmaceuticals Major industry is in the same range as PRME (100) in the null industry. This means that WHWK’s stock grew similarly to PRME’s over the last 12 months.

WHWK's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as PRME (96) in the null industry. This means that WHWK’s stock grew similarly to PRME’s over the last 12 months.

WHWK's Price Growth Rating (89) in the Pharmaceuticals Major industry is in the same range as PRME (96) in the null industry. This means that WHWK’s stock grew similarly to PRME’s over the last 12 months.

WHWK's P/E Growth Rating (93) in the Pharmaceuticals Major industry is in the same range as PRME (100) in the null industry. This means that WHWK’s stock grew similarly to PRME’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRMEWHWK
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 30 days ago
78%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PED0.560.01
+2.66%
PEDEVCO Corp
PEB8.700.20
+2.35%
Pebblebrook Hotel Trust
HAS52.650.77
+1.48%
Hasbro
AAPL196.982.71
+1.39%
Apple
TBPH8.620.02
+0.29%
Theravance Biopharma

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
N/A
CRSP - PRME
63%
Loosely correlated
-0.03%
RXRX - PRME
60%
Loosely correlated
+3.38%
BEAM - PRME
58%
Loosely correlated
+2.29%
NTLA - PRME
57%
Loosely correlated
+5.39%
ABCL - PRME
54%
Loosely correlated
+1.26%
More

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
+1.95%
AXON - WHWK
44%
Loosely correlated
-2.15%
DMAC - WHWK
43%
Loosely correlated
+2.02%
GOSS - WHWK
41%
Loosely correlated
+1.49%
AMRN - WHWK
37%
Loosely correlated
-2.67%
PRME - WHWK
37%
Loosely correlated
N/A
More